Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic association studies in drug-induced liver injury.

Drug metabolism reviews - 1 Feb 2012

Daly Ann K, Day Christopher P

Abstract excerpt

A large number of case-control association studies on genetic susceptibility to drug-induced liver injury, involving both candidate gene and genome-wide association approaches, have now been reported. The strongest associations have been observed for human leukocyte antigen (HLA) class I and II genes and N-acetyltransferase 2 (NAT2). The associations with HLA class I and II genes are drug specific, though some...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Chemical and Drug Induced Liver Injury
Share to Drug-Related Side Effects and Adverse Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, MHC Class I

Share to HLA Antigens

Share to Immunity, Innate

Share to Isoniazid

Share to Pharmaceutical Preparations

Source

Identifiers

PMID: 21913872
DOI: 10.3109/03602532.2011.605790

Genes

NAT2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic association studies in drug-induced liver injury.PMID 21913872Read ↗

Genetic association studies in drug-induced liver injury.Semantic proximity Read ↗

Genetics of drug-induced liver injury: Current knowledge and future prospects.Semantic proximity Read ↗

Drug-induced liver injury: past, present and future.Semantic proximity Read ↗

Recent progress in genetic variation and risk of antituberculosis drug-induced liver injury.Semantic proximity Read ↗

Genetic and Genomic Approaches to the Study of Drug-Induced Liver Injury.Semantic proximity Read ↗

Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens.Semantic proximity Read ↗

Genome-Wide Association Studies in Drug-Induced Liver Injury: Step Change in Understanding the Pathogenesis.Semantic proximity Read ↗

Drug-Induced Liver Injury: Insights from Genetic StudiesSemantic proximity Read ↗

Epigenetic modifications in idiosyncratic drug-induced liver injury: A systematic reviewSemantic proximity Read ↗

N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group.Semantic proximity Read ↗

Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury?Semantic proximity Read ↗

Pharmacogenomics in drug induced liver injury.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.